195
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Endogenous Fungal Endophthalmitis Associated with Genitourinary Procedures

, MDORCID Icon, , MD, , PhD, , PhD, & , PhD
Pages 747-755 | Received 18 Jan 2018, Accepted 11 Apr 2018, Published online: 11 Jul 2018

REFERENCES

  • Durand ML. Bacterial and Fungal Endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613.
  • Ramakrishnan R, Bharathi MJ, Shivkumar C, et al. Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis: a 10-year retrospective study. Eye (Lond). 2009;23(4):945–956.
  • Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand. 2007;85:852–856.
  • Feman SS, Nichols JC, Chung SM, Theobald TA. Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc. 2002;100:67–70.
  • Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004;137:820–825.
  • Takebayashi H, Mizota A, Tanaka M. Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol. 2006;244:816–820.
  • Essman TF, Flynn HW Jr, Smiddy WE, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1997;28(3):185–194.
  • Schiedler V, Scott IU, Flynn HW, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137(4):725–731.
  • Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis. An 18-year review of culture-positive cases at a tertiary care center. Medicine. 2003;82(2):97–105.
  • Kostick DA, Foster RE, Lowder CY, Meyers SM, McHenry MC. Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol. 1992;113(5):593–595.
  • Chavan R, Mustafa MZ, Narendran N, Tarin S, Yang Y. A case of Candida albicans endophthalmitis with no predisposing risk factors and a distant source of infection. Case Rep Ophthalmol. 2012;3:277–282.
  • Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm. 2009;17(3):148–152.
  • Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M, Qiu H. Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients. Retina. 2001;21(3):203–209.
  • Ghoraba HH, Ellakwa AF, Elgemai EM, Mansour HO, Heikal MA. Results of pars plana vitrectomy for the management of endogenous fungal endophthalmitis after urinary tract procedures. Retin Cases Brief Rep. 2017;11(2):171–174.
  • Chen SJ, Chung YM, Liu JH. Endogenous Candida endophthalmitis after induced abortion. Am J Ophthalmol. 1998;125(6):873–875.
  • Sikić J, Vukojević N, Katusić D, Sarić B. Bilateral endogenous Candida endophthalmitis after induced abortion. Croat Med J. 2001;42(6):676–678.
  • Doshi RR, Wender JD, Jumper JM, Sanislo SR, Leng T. Endogenous Candida albicans endophthalmitis following spontaneous abortion and IUD removal. Ophthalmic Surg Lasers Imaging. 2011;42:e132–134.
  • Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445–1456.
  • Pettit TH, Edwards JE, Purdy EP, et al. Endogenous fungal endophthalmitis. In: Pepose JS, Holland GN, Wilhelmus KR. eds. Ocular Infection and Immunity. St. Louis, MO: Mosby YearBook; 1996. 1262–1285.
  • Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther. 2011;9:1191–1201.
  • Sallam A, Lynn W, McCluskey P, Lightman S. Endogenous Candida endophthalmitis. Expert Rev Anti Infect Ther. 2006;4:675–685.
  • Patel SN, Rescigno RJ, Zarbin MA, Langer P, Bhagat N. Endogenous endophthalmitis associated with intravenous drug abuse. Retina. 2014;34(7):1460–1465.
  • Connell PP, O’Neill EC, Amirul Islam FM, et al. Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina. 2010;30(10):1721–1725.
  • Sallam A, Taylor SR, Khan A, et al. Factors determining visual outcome in endogenous Candida endophthalmitis. Retina. 2012;32(6):1129–1134.
  • Lingappan A, Wykoff CC, Albini TA, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153(1):162–166.
  • Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore). 1974;53:47–75.
  • Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159(3):498–504.
  • Lass-Flörl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs. 2011;71(18):2405–2419.
  • Mochizuki K, Niwa Y, Ishida K, Kawakami H. Intraocular penetration of itraconazole in patient with fungal endophthalmitis. Int Ophthalmol. 2013;33(5):579–581.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of Candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–50.
  • Potter M. Strategies for managing systemic fungal infection and the place of itraconazole. J Antimicrob Chemother. 2005;56(Suppl 1):i49–i54.
  • Piérard GE, Arrese JE. Piérard-Franchimont C. Itraconazole. Expert Opin Pharmacother. 2000;1(2):287–304.
  • Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina. 2008;28(10):1400–1407.
  • Cannon JP, Fiscella R, Pattharachayakul S, et al. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci. 2003;44(5):2112–2117.
  • William A, Spitzer MS, Deuter C, et al. Outcomes of primary transconjunctival 23-gauge vitrectomy in the diagnosis and treatment of presumed endogenous fungal endophthalmitis. Ocul Immunol Inflamm. 2017;25(2):239–245.
  • Zhang YQ, Wang WJ. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina. 2005;25(6):746–750.
  • Birnbaum FA, Gupta G. The role of early vitrectomy in the treatment of fungal endogenous endophthalmitis. Retin Cases Brief Rep. 2016;10(3):232–235.
  • Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J, et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis. 1998;27:1130–1133.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.